Chao Jing Selected Research

Antisense RNA (Anti-Sense RNA)

1/2018

STAT3/HOTAIR Signaling Axis Regulates HNSCC Growth in an EZH2-dependent Manner.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chao Jing Research Topics

Disease

16	Neoplasms (Cancer) 12/2023 - 03/2014
12	Neoplasm Metastasis (Metastasis) 03/2024 - 02/2015
9	Squamous Cell Carcinoma of Head and Neck 03/2024 - 01/2017
5	Lymphatic Metastasis 01/2023 - 12/2015
4	Esophageal Squamous Cell Carcinoma 06/2021 - 12/2015
3	Adenocarcinoma 01/2023 - 10/2021
3	Papillary Thyroid Cancer 01/2022 - 01/2021
3	Breast Neoplasms (Breast Cancer) 01/2017 - 06/2013
2	Colonic Neoplasms (Colon Cancer) 07/2023 - 03/2014
2	Disease Progression 11/2022 - 10/2021
2	Esophageal Neoplasms (Esophageal Cancer) 06/2021 - 01/2017
2	Carcinogenesis 03/2014 - 06/2013
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 06/2013 - 02/2012
1	Chronic Obstructive Pulmonary Disease (COPD) 07/2023
1	Microsatellite Instability 07/2023
1	Thyroid Neoplasms (Thyroid Cancer) 01/2023
1	Adenocarcinoma of Lung 01/2023
1	Fatigue 11/2022
1	Intestinal Obstruction (Obstruction, Intestinal) 11/2022
1	Proteinuria 11/2022
1	Thrombocytopenia (Thrombopenia) 11/2022
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2022
1	Hypoxia (Hypoxemia) 06/2021
1	Ovarian Neoplasms (Ovarian Cancer) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 01/2019

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 03/2024 - 03/2014
4	Deubiquitinating EnzymesIBA 12/2023 - 01/2021
4	CateninsIBA 12/2023 - 01/2017
4	Proteins (Proteins, Gene)FDA Link 07/2021 - 06/2013
4	MicroRNAs (MicroRNA)IBA 06/2021 - 02/2015
3	Long Noncoding RNAIBA 08/2023 - 01/2018
3	Cisplatin (Platino)FDA LinkGeneric 07/2021 - 01/2017
2	LigandsIBA 07/2023 - 01/2023
2	apatinibIBA 11/2022 - 10/2021
2	Thyroglobulin FDA Link 01/2022 - 12/2021
2	PlatinumIBA 10/2021 - 01/2018
2	acetopyrrothine (thiolutin)IBA 01/2021 - 01/2021
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2019 - 01/2017
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2023
1	Biotin (Vitamin H)FDA Link 01/2023
1	dabrafenibIBA 01/2023
1	Hypoxia-Inducible Factor 1IBA 01/2023
1	LuciferasesIBA 01/2023
1	Therapeutic UsesIBA 01/2023
1	Peptides (Polypeptides)IBA 01/2023
1	Thyroid HormonesIBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	Transaminases (Aminotransferases)IBA 11/2022
1	camrelizumabIBA 11/2022
1	Monoclonal AntibodiesIBA 11/2022
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2022
1	ceric oxide (cerium dioxide)IBA 06/2021
1	AntioxidantsIBA 06/2021
1	graphdiyneIBA 06/2021
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 06/2021
1	ElementsIBA 06/2021
1	CatalaseIBA 06/2021
1	SphingomyelinsIBA 01/2021
1	EnzymesIBA 01/2021
1	Capsules (Microcapsules)IBA 01/2021
1	phosphatidylcholine-ceramide phosphocholine transferaseIBA 01/2021
1	WP1066IBA 01/2018
1	Antisense RNA (Anti-Sense RNA)IBA 01/2018
1	Cetuximab (Erbitux)FDA Link 01/2018
1	IntegrinsIBA 01/2017
1	epidermal growth factor receptor VIIIIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 01/2017
1	Transforming Growth Factor-beta Type II ReceptorIBA 01/2016
1	Carrier Proteins (Binding Protein)IBA 12/2015
1	GoldIBA 06/2013
1	indium tin oxideIBA 02/2012

Therapy/Procedure

13	Therapeutics 07/2023 - 01/2016
2	Radiotherapy 01/2023 - 06/2021
1	Immunotherapy 07/2023
1	Induction Chemotherapy 01/2023
1	Adjuvant Chemotherapy 01/2022
1	Lymph Node Excision (Lymph Node Dissection) 01/2021
1	Thyroidectomy 01/2021